Skip to content
Dr. Grey AI

Supplement

Cannabidiol (CBD)

Cannabidiol, or CBD, is a non-intoxicating compound from the cannabis plant that interacts with several signaling systems in the brain, including those that help calm overactive nerve activity. People most often look at it for seizures in treatment-resistant epilepsy, and large trials found people had fewer seizures, including fewer drop seizures in Lennox-Gastaut syndrome, with the evidence rated strong. Findings for anxiety were far thinner, coming from small studies with only 57 people in total, so that evidence is limited.

Sources: PMID 40217555; PMID 29768152

Best evidence
Grade A
Conditions studied
14
Outcomes
19
Graded outcomes
1010

Evidence by condition

  • Strong
  • Moderate
  • Limited
  • Very limited

14 conditions

Epilepsy: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Seizure Frequency

Large Improvement

Improves (the measure goes down)Large effect4 studies1,829 people
Mood Improvement: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Anxiety Symptoms

Moderate Improvement

Improves (the measure goes down)Moderate effect5 studies57 people
AttentionImproves (the measure goes up)60 people
CognitionImproves (the measure goes up)60 people
Depression SymptomsImproves (the measure goes down)60 people
MoodImproves (the measure goes up)60 people
Working MemoryImproves (the measure goes up)60 people

Mental Resilience

  • Anxiety Symptoms: improves
Mental Resilience: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Anxiety SymptomsImproves (the measure goes down)5 studies48 people

Paranoia

  • Anxiety Symptoms: improves
Paranoia: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Anxiety SymptomsImproves (the measure goes down)5 studies32 people

Stress

  • Anxiety Symptoms: improves
Stress: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Anxiety SymptomsImproves (the measure goes down)5 studies60 people

Tuberous Sclerosis Complex (TSD)

  • Seizure Frequency: changes; see studies
Tuberous Sclerosis Complex (TSD): outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Seizure FrequencyChanges; see studies4 studies56 people
Multiple Sclerosis (MS): outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
PainImproves (the measure goes down)3 studies24 people

Autonomic Dysfunction

  • Pain: improves
Autonomic Dysfunction: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
PainImproves (the measure goes down)3 studies12 people
Brachial plexus damage: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
PainImproves (the measure goes down)3 studies24 people

Spinal Cord Injury

  • Pain: improves
Spinal Cord Injury: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
PainImproves (the measure goes down)3 studies24 people

Surgical Recovery

  • Pain: improves
Surgical Recovery: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
PainImproves (the measure goes down)3 studies7 people

Schizophrenia

  • Schizophrenia symptoms: improves
Schizophrenia: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Schizophrenia symptomsImproves (the measure goes down)2 studies124 people

Crohn's Disease

  • Crohn's Disease Symptoms: improves
Crohn's Disease: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Crohn's Disease SymptomsImproves (the measure goes down)1 study20 people

Ulcerative Colitis

  • Ulcerative Colitis Symptoms: improves
Ulcerative Colitis: outcomes studied for Cannabidiol (CBD)
GradeOutcomeEffectSizeStudiesPeopleStudies list
Ulcerative Colitis SymptomsImproves (the measure goes down)1 study60 people

Key findings

  • Seizure FrequencyEpilepsyImproves (the measure goes down)
  • Anxiety SymptomsMood ImprovementImproves (the measure goes down)

Shop the evidence-backed picks

Third-party tested Cannabidiol (CBD) products, in the forms the graded studies used where we can match them.

  • Grade A

Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure

Studies cited

17 studies from PubMed

  1. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy VolunteersFront Psychiatry · PMID 33304282
  2. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking testBraz J Psychiatry · PMID 30328956
  3. The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid groupJ Psychopharmacol · PMID 29086614
  4. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled TrialAm J Psychiatry · PMID 29241357
  5. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trialPsychopharmacology · PMID 29619533
  6. Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled TrialDig Dis Sci · PMID 28349233
  7. Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real LifeFront Pharmacol · PMID 28553229
  8. Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjectsPsychopharmacology · PMID 6285406
  9. Effects of ipsapirone and cannabidiol on human experimental anxietyJ Psychopharmacol · PMID 22290374
  10. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative ColitisInflamm Bowel Dis · PMID 29538683
  11. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut SyndromeN Engl J Med · PMID 29768152
  12. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trialLancet Neurol · PMID 26724101
  13. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complexEpilepsia · PMID 27696387
  14. The efficacy of cannabidiol for seizures reduction in pharmacoresistant epilepsy: a systematic review and meta-analysis.Acta Epileptol · PMID 40217555
  15. Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in UruguayTransplant Proc · PMID 29579828
  16. Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus VaccinationIsr Med Assoc J · PMID 28457055
  17. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptomsClin Rehabil · PMID 12617376